InvestorsHub Logo
Followers 3
Posts 130
Boards Moderated 1
Alias Born 05/07/2012

Re: None

Tuesday, 03/12/2013 3:40:53 PM

Tuesday, March 12, 2013 3:40:53 PM

Post# of 689
Prospectus presentation
Link

Some new material in linked presentation. I think it's a good idea that they have gone ahead and highlighted the platform possibilities as future upside (diabetes, etc.). Also, well done on management's part by highlighting the near term catalysts. This investment at today's price is very much like a venture capital investment in terms of getting in on the ground floor, but unlike VC the story has near term significant catalysts. The market likes platform stories as long as the payoff is not too far in the future.

Assuming the financing goes off at 10 cents and a 50:1 ratio, the stock will start out post-financing at $5/share and have a $35MM market cap. I think it will take little time at all for the stock to triple from there. That would be a $100MM market cap and still be a compelling investment story going forward. The old market cap high of $150MM should be well within reach prior to Phase 2b results ($22.5/share post-split and 45 cents pre-split. That's a 350% return from current levels inside of a year...

The thing to do is to separate the past and look at the investment going forward. The science is impressive and it's a new CEO going forward.

I will likely be participating in the offering or at least buy additional shares in the open market as I like the story still and the valuation is as good as it gets for new money.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.